Avila raises $30 million

Avila Therapeutics Inc. (Waltham, Mass.) raised $30 million in a series B round led by new investor Novartis Option Fund. Existing investors Abingworth; Advent Venture Partners; Atlas Venture; and Polaris Venture Partners also participated. ...